| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2243a54fef78f99c39546c86983fb218
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2658d45a8e9c71b9598e2bf83242bab3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
1995-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13f40d7aa7d1cd4f4d8d05d1a2afc9f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b57735d432dfa3e9af407e9b9c2f683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_528765bc591a166b28c322a1de9ff3c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b89dc1cde49158045fd8efd866a30dfe |
| publicationDate |
2001-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2188284-C |
| titleOfInvention |
Group a streptococcal polysaccharide immunogenic compositions and methods |
| abstract |
This invention provides a novel immunogenic composition and vaccine, process es for producing them and methods for immunization against infections and disease caused by group A Streptococci. The compositi ons include group A streptococcal polysaccharide covalen tly linked to protein or liposomes to form immunogenic conjugates. The method of immunization for this invention comprises administering to an individual an immunogenic amount of group A polysaccharide. The group A p olysaccharide may be administered as a vaccine either on its own, conjugated to proteins or conjugated to liposomes. Additionally, th e group A polysaccharides may be associated with an adju vant. This invention is particularly useful for providing both active and passive immunogenic protection for those populations most at ris k of contracting group A Streptococcal infections and disease namely adults, preg nant women and in particular infants and children. |
| priorityDate |
1994-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |